Literature DB >> 20413768

Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings.

Aurélie Drier1, Julien Haroche, Julien Savatovsky, Gaelle Godenèche, Didier Dormont, Jacques Chiras, Zahir Amoura, Fabrice Bonneville.   

Abstract

PURPOSE: To retrospectively review the brain magnetic resonance (MR) imaging and computed tomographic (CT) findings in patients with Erdheim-Chester disease (ECD).
MATERIALS AND METHODS: The ethics committee required neither institutional review board approval nor informed patient consent for retrospective analyses of the patients' medical records and imaging data. The patients' medical files were retrospectively reviewed in accordance with human subject research protocols. Three neuroradiologists in consensus analyzed the signal intensity, location, size, number, and gadolinium uptake of lesions detected on brain MR images obtained in 33 patients with biopsy-proved ECD.
RESULTS: Thirty patients had intracranial, facial bone, and/or orbital involvement, and three had normal neurologic imaging findings. The hypothalamic-pituitary axis was involved in 16 (53%) of the 30 patients, with six (20%) cases of micronodular or nodular masses of the infundibular stalk. Meningeal lesions were observed in seven (23%) patients. Three (10%) patients had bilateral symmetric T2 high signal intensity in the dentate nucleus areas, and five (17%) had multiple intraaxial enhancing masses. Striking intracranial periarterial infiltration was observed in three (10%) patients. Another patient (3%) had a lesion in the lumen of the superior sagittal sinus. Nine (30%) patients had orbital involvement. Twenty-four (80%) patients had osteosclerosis of the facial and/or skull bones. At least two anatomic sites were involved in two-thirds (n = 20) of the patients. Osteosclerosis of the facial bones associated with orbital masses and either meningeal or infundibular stalk masses was seen in eight (27%) patients.
CONCLUSION: Lesions of the brain, meninges, facial bones, and orbits are frequently observed and should be systematically sought on the brain MR and CT images obtained in patients with ECD, even if these patients are asymptomatic. Careful attention should be directed to the periarterial environment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413768     DOI: 10.1148/radiol.10090320

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  49 in total

1.  Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease.

Authors:  P Sedrak; L Ketonen; P Hou; N Guha-Thakurta; M D Williams; R Kurzrock; J M Debnam
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

2.  Erdheim-Chester disease presenting with an intramedullary spinal cord lesion.

Authors:  Charalampos Tzoulis; Ivar Otto Gjerde; Eirik Søfteland; Gesche Neckelmann; Eivind Strøm; Olav Karsten Vintermyr; Lisbeth Sviland; Martin Biermann
Journal:  J Neurol       Date:  2012-05-26       Impact factor: 4.849

Review 3.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

4.  Erdheim-Chester disease: yellow-tinge appearance on neuroendoscopic imaging.

Authors:  Tomoya Kon; Haruo Nishijima; Hiroyuki Kon; Mika Watanabe; Masahiko Tomiyama
Journal:  Neurol Sci       Date:  2015-07-15       Impact factor: 3.307

5.  Whole body positron emission tomography-MRI of Erdheim-Chester disease: a case report.

Authors:  Nunzia Garbino; Bruna Punzo; Antonio Todisco; Giovanni Cirillo; Carlo Cavaliere
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 6.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

7.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

8.  Erdheim-Chester disease: description of eight cases.

Authors:  S Roverano; J Gallo; A Ortiz; N Migliore; Mónica Eletti; S Paira
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

9.  Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease.

Authors:  Luisa Chiapparini; Giulio Cavalli; Tiziana Langella; Anna Venerando; Giacomo De Luca; Sergio Raspante; Giorgio Marotta; Bianca Pollo; Giuseppe Lauria; Maria Giulia Cangi; Simonetta Gerevini; Andrea Botturi; Davide Pareyson; Lorenzo Dagna; Ettore Salsano
Journal:  J Neurol       Date:  2017-12-04       Impact factor: 4.849

10.  Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.

Authors:  Moozhan Nikpanah; Lauren Kim; S Mojdeh Mirmomen; Rolf Symons; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.